Investor Relations Overview

We are aware of how important transparency is in evaluating your investment decision. In the following pages you will have access to our most up-to-date quarterly financial reports, conference calls and annual reports. Should you require additional information that you cannot find in these pages, please do not hesitate to contact us.
FINANCIAL NEWS
09/15/14
Danaher to Acquire Nobel Biocare Holding AG for CHF 17.10 per share
- Danaher Corporation announces all-cash tender offer for all publicly held registered shares of Nobel Biocare Holding AG ("Nobel Biocare") at a purchase price of CHF 17.10 per share, representing a total enterprise value of approximately $2.2 billion including debt assumed and net of cash acquired, recommended by Nobel Biocare's Board of Directors. WASHINGTON, Sept. 15, 2014 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) has entered into a definitive transaction agreement with Nobel Biocare ... 

09/09/14
Danaher Announces Quarterly Dividend
WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.10 per share payable on October 31, 2014 to holders of record on September 26, 2014. About DanaherDanaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands have unparalleled leadership positions in s... 

09/09/14
Danaher to Present at Morgan Stanley Laguna Conference
WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will present at the Morgan Stanley Laguna Conference in Dana Point, California on Tuesday, September 16 at 8:00 a.m. PT.  The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.    About DanaherDanaher is a global science and technology innovator committed to helping its customers solve complex cha... 

09/02/14
Danaher Corporation Appoints Thomas P. Joyce, Jr. As President And CEO
WASHINGTON, Sept. 2, 2014 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced that the Company's Board of Directors has implemented its previously disclosed succession plan and will appoint Thomas P. Joyce, Jr. as President and Chief Executive Officer and a member of the Board of Directors, effective September 9, 2014. Mr. Joyce's predecessor, H. Lawrence Culp, Jr., will transition to a senior advisory role. Steven M. Rales, Chairman of the Board of Directors, stated, "The transit... 

STOCK QUOTE

$79.36 Stock is Up 0.63

Danaher Corporation (DHR: Common Stock)09/18/14 4:00 p.m. ET
Minimum 20 minute delay
Stock chart for: 03NA000000DHR

CONTACT INVESTOR RELATIONS
Danaher Corporation
2200 Pennsylvania Ave, NW
Suite 800W
Washington, DC 20037
202-828-0850
Email: investor.relations@danaher.com

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.